The hepatokine RBP4 links metabolic diseases to articular inflammation.

Pazos-Pérez A. et al.

Antioxidants (2024)

Formononetin, a beer polyphenol with catabolic effects on chondrocytes.

Guillán-Fresco M. et al.

Nutrients (2023)

DNA methylation analysis identifies key transcription factors involved in mesenchymal stem cell osteogenic differentiation.

Rodolfo Gómez et al.

Biol Res (2023)

β Boswellic Acid Blocks Articular Innate Immune Responses: an in silico & in vitro approach to traditional medicine.

Franco-Trepat E. et al.

Antioxidants (2023)

Methylphenidate promotes premature growth plate closure: in vitro evidences.

Pazos-Pérez A. et al.

IJMC (2023)

Improved protocol to study osteoblast and adipocyte differentiation balance.

Alonso-Pérez A. et al.

Biomedicines 11(1), 31 (2023)

Repurposing drugs to inhibit innate immune responses associated with TLR4, IL1, and NLRP3 signaling in joint cells.

Franco-Trepat E. et al.

Biomedicine & Pharmacotherapy (Vol 115) (2022)

Amitriptyline blocks innate immune responses mediated by toll-like receptor 4 and IL-1 receptor: Preclinical and clinical evidence in osteoarthritis and gout.

Franco-Trepat E. et al.

BJP, 179-2, 270-286 (2022)

Caffeine, a Risk Factor for Osteoarthritis and Longitudinal Bone Growth Inhibition.

Guillán-Fresco, M. et al.

J Clin Med 9, (2020).

Visfatin Connection: Present and Future in Osteoarthritis and Osteoporosis.

Franco-Trepat, E. et al.

J Clin Med 8, (2019).

Visfatin as a therapeutic target for rheumatoid arthritis.

Franco-Trepat, E. et al.

Expert Opin. Ther. Targets 23, 607–618 (2019).

Early outcomes of locked noncemented stems for the management of proximal humeral fractures: a comparative study.

Jorge-Mora, A. et al.

J Shoulder Elbow Surg 28, 48–55 (2019).

In vitro response of bone marrow mesenchymal stem cells (hBMSCs) on laser-induced periodic surface structures for hard tissue replacement: Comparison between tantalum and titanium.

Jorge-Mora, A. et al.

Optics and Lasers in Engineering 111, 34–41 (2018).

Role of Toll-Like Receptor 4 on Osteoblast Metabolism and Function.

Alonso-Pérez, A. et al.

Front. Physiol. 9, 504 (2018).

The adipokine lipocalin-2 in the context of the osteoarthritic osteochondral junction.

Villalvilla, A. et al.

Sci Rep 6, 29243–29243 (2015).

TLR4 signalling in osteoarthritis-finding targets for candidate DMOADs.

Gómez, R. et al.

Nat Rev Rheumatol 11, 159–170 (2015).

6-Shogaol inhibits chondrocytes’ innate immune responses and cathepsin-K activity.

Villalvilla, A. et al.

Mol Nutr Food Res 58, 256–266 (2014).

What’s new in our understanding of the role of adipokines in rheumatic diseases?

Gómez, R. et al.

Nat Rev Rheumatol 7, 528–536 (2011).

Adiponectin and leptin increase IL-8 production in human chondrocytes.

Gómez, R. et al.

Ann Rheum Dis 70, 2052–2054 (2011).

Effect of oleocanthal and its derivatives on inflammatory response induced by lipopolysaccharide in a murine chondrocyte cell line.

Iacono, A. et al.

Arthritis Rheum 62, 1675–1682 (2010).

Expression and modulation of ghrelin O-acyltransferase in cultured chondrocytes.

Gómez, R. et al.

Arthritis Rheum 60, 1704–1709 (2009).

Novel factors as therapeutic targets to treat diabetes. Focus on leptin and ghrelin.

Gómez, R. et al.

Expert Opin. Ther. Targets 13, 583–591 (2009).